Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients
Clinical trial NCT00938314 · TERMINATED
Trial details
- NCT number
- NCT00938314
- Sponsor
- Stem Cell Therapeutics Corp.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2010-04-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.